Harnessing Cell Migration to Repair Tissue Using RNAi-Enabled Therapeutics

Time: 4:10 pm
day: Agenda


• We have identified several previously unknown or uncharacterized microtubule regulatory proteins that, when knocked-down using siRNA, demonstrate dramatic therapeutic benefits – especially in tissue repair after trauma
• MicroCures has completed extensive animal studies on its drug candidate, siFi2, and plans to begin first-in-human clinical trials in late 2020